Literature DB >> 24493069

Sticker shock and the price of new therapies for hepatitis C: is it worth it?

Nancy S Reau1, Donald M Jensen.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 24493069     DOI： 10.1002/hep.27039

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  20 in total

1.  Sofosbuvir: a new oral once-daily agent for the treatment of hepatitis C virus infection.

Authors:  Agnes Cha; Aliaksandr Budovich
Journal:  P T       Date:  2014-05

2.  A Budget Impact Analysis of Newly Available Hepatitis C Therapeutics and the Financial Burden on a State Correctional System.

Authors:  John T Nguyen; Josiah D Rich; Bradley W Brockmann; Fred Vohr; Anne Spaulding; Brian T Montague
Journal:  J Urban Health       Date:  2015-08       Impact factor: 3.671

Review 3.  Treatment of hepatitis C in difficult-to-treat patients.

Authors:  Peter Ferenci
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-04-21       Impact factor: 46.802

4.  Excluding people who use drugs or alcohol from access to hepatitis C treatments – Is this fair, given the available data?

Authors:  Jason Grebely; Bridget Haire; Lynn E Taylor; Paul Macneill; Alain H Litwin; Tracy Swan; Jude Byrne; Jules Levin; Philip Bruggmann; Gregory J Dore
Journal:  J Hepatol       Date:  2015-08-04       Impact factor: 25.083

5.  Intradermal delivery of DNA encoding HCV NS3 and perforin elicits robust cell-mediated immunity in mice and pigs.

Authors:  B Grubor-Bauk; W Yu; D Wijesundara; J Gummow; T Garrod; A J Brennan; I Voskoboinik; E J Gowans
Journal:  Gene Ther       Date:  2015-10-01       Impact factor: 5.250

Review 6.  Era of direct acting antivirals in chronic hepatitis C: Who will benefit?

Authors:  James Fung
Journal:  World J Hepatol       Date:  2015-10-28

Review 7.  Hepatitis C: Treatment of difficult to treat patients.

Authors:  Eric G Hilgenfeldt; Alex Schlachterman; Roberto J Firpi
Journal:  World J Hepatol       Date:  2015-07-28

Review 8.  Treatment of Hepatitis C during Pregnancy-Weighing the Risks and Benefits in Contrast to HIV.

Authors:  A Sidney Barritt; Ravi Jhaveri
Journal:  Curr HIV/AIDS Rep       Date:  2018-04       Impact factor: 5.071

9.  The cost-effectiveness of sofosbuvir-based regimens for treatment of hepatitis C virus genotype 2 or 3 infection.

Authors:  Benjamin P Linas; Devra M Barter; Jake R Morgan; Mai T Pho; Jared A Leff; Bruce R Schackman; C Robert Horsburgh; Sabrina A Assoumou; Joshua A Salomon; Milton C Weinstein; Kenneth A Freedberg; Arthur Y Kim
Journal:  Ann Intern Med       Date:  2015-05-05       Impact factor: 51.598

10.  Cost-effectiveness of Interferon-free therapy for Hepatitis C in Germany--an application of the efficiency frontier approach.

Authors:  Christian Gissel; Georg Götz; Jörg Mahlich; Holger Repp
Journal:  BMC Infect Dis       Date:  2015-07-30       Impact factor: 3.090
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.